Cresset Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$28.51 - $32.9 $253,624 - $292,678	-8,896 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$26.37 - $34.22 $234,587 - $304,421	8,896 New	8,896 $259,000
Q2 2019 Aug 12, 2019	SELL	$29.96 - $38.87 $4,763 - $6,180	-159 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $65 - $83	-2 Reduced 1.24%	159 $6,000
Q4 2018 May 21, 2019	BUY	$30.84 - $49.51 $4,965 - $7,971	161 New	161 $5,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.